PHASE-II STUDIES OF MITOXANTRONE (DIHYDROXYANTHRACENEDIONE) IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA

被引：31

作者：

DESIMONE, PA

GAMS, R

BARTOLUCCI, A

机构：

[1] UNIV KENTUCKY, SCH MED,DEPT MED,DIV HEMATOL ONCOL, COMM GI PHASE 2,SE COOPERAT CANC STUDY GRP, LEXINGTON, KY 40506 USA

[2] UNIV ALABAMA, SCH MED,DEPT MED,DIV HEMATOL ONCOL, SE COOPERAT CANC STUDY GRP, BIRMINGHAM, AL 35233 USA

[3] UNIV ALABAMA, SCH MED, DEPT BIOSTAT, SE COOPERAT CANC STUDY GRP, BIRMINGHAM, AL 35233 USA

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1984年 / 7卷 / 05期

关键词：

D O I：

10.1097/00000421-198410000-00024

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients with advanced colon carcinoma were treated with mitoxantrone 5 mg/m2 i.v. weekly. The 104 patients were stratified into 2 groups: prior chemotherapy and no prior chemotherapy. Only 1 partial response was noted in the prior treatment category.

引用

页码：517 / 522

页数：6